Advertisement

Monitoring of MMPs activity in vivo, non-invasively, using solubility switchable MRI contrast agent

  • Beata Jastrzebska
  • Rejean Lebel
  • Oliver J. McIntyre
  • Benoit Paquette
  • Witold Neugebauer
  • Emanuel Escher
  • Martin Lepage
Part of the Advances in Experimental Medicine and Biology book series (volume 611)

Keywords

Magnetic Resonance Imaging Contrast Magnetic Resonance Imaging Contrast Agent Gadolinium Chelate Contrast Agent Concentration Normal Biological Process 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

This work was supported by the National Cancer Institute of Canada. We acknowledge the help of H. Therriault, M. Archambault, C. Dubuc and V. Dumulon. ML is the Canada Research Chair in magnetic resonance imaging.

References

  1. 1.
    Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz C. M., and Shafie S. Nature 284, 67–68 (1980).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Beata Jastrzebska
    • 1
    • 2
  • Rejean Lebel
    • 1
    • 2
  • Oliver J. McIntyre
    • 3
  • Benoit Paquette
    • 2
  • Witold Neugebauer
    • 4
  • Emanuel Escher
    • 4
  • Martin Lepage
    • 1
    • 2
  1. 1.Sherbrooke Molecular Imaging CentreUniversité de SherbrookeSherbrookeCanada
  2. 2.Department of Nuclear Medicine and RadiobiologyUniversité de SherbrookeSherbrookeCanada
  3. 3.Department of Cancer Biology and Vanderbilt-Ingram Cancer CenterVanderbilt UniversityNashvilleUSA
  4. 4.Department of PharmacologyUniversité de SherbrookeSherbrookeCanada

Personalised recommendations